Merck’s cancer drug Keytruda is expected to be the top-selling drug globally in 2024, according to data published by Statista.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
10 drugs poised to be best-sellers in 2024
Merck’s cancer drug Keytruda is expected to be the top-selling drug globally in 2024, according to data published by Statista.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis